2023
DOI: 10.1016/j.ejr.2022.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Life threatening macrophage activation syndrome as the initial presentation of systemic lupus erythematosus: A case report and review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 44 publications
0
2
0
Order By: Relevance
“…These immunosuppressive medications are commonly selected due to their dual efficacy against the underlying rheumatic disease and MAS. IVIg is not effective as a monotherapy and typically used in combination with other medications [4].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…These immunosuppressive medications are commonly selected due to their dual efficacy against the underlying rheumatic disease and MAS. IVIg is not effective as a monotherapy and typically used in combination with other medications [4].…”
Section: Discussionmentioning
confidence: 99%
“…Macrophage activation syndrome (MAS) is characterized by excessive activation of macrophages and lymphocytes, resulting to multiorgan dysfunction. As the initial manifestation of systemic lupus erythematosus (SLE), MAS is rare in children [4].…”
Section: Introductionmentioning
confidence: 99%